Karine Provost

UMR 7182 CNRS, UPEC, PRES Paris Est
Thiais, 94320, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Unveiling the Ir single atoms as selective active species for the partial hydrogenation of butadiene by operando XAS.

Unveiling the Ir single atoms as selective active species for the partial hydrogenation of butadiene by operando XAS.

Journal: Nanoscale

Published: May 13, 2022

Site Occupancy Determination in Th2Zn17- and TbCu7-types Sm2Fe17-xCox Compounds using Synchrotron Resonant Diffraction.

Site Occupancy Determination in Th2Zn17- and TbCu7-types Sm2Fe17-xCox Compounds using Synchrotron Resonant Diffraction.

Journal: Inorganic chemistry

Published: January 13, 2021

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

Journal: Haematologica

Published: November 05, 2018

Investigation of the local structure of nanosized rhodium hydride.

Investigation of the local structure of nanosized rhodium hydride.

Journal: Journal of colloid and interface science

Published: January 22, 2018

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.

Journal: The European respiratory journal

Published: June 18, 2017

Composition and size dependence of hydrogen interaction with carbon supported bulk-immiscible Pd-Rh nanoalloys.

Composition and size dependence of hydrogen interaction with carbon supported bulk-immiscible Pd-Rh nanoalloys.

Journal: Nanotechnology

Published: October 26, 2016

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.

Journal: JAMA

Published: July 08, 2015

EXAFS Debye-Waller factors issued from Car-Parrinello molecular dynamics: application to the fit of oxaliplatin and derivatives.

EXAFS Debye-Waller factors issued from Car-Parrinello molecular dynamics: application to the fit of oxaliplatin and derivatives.

Journal: The Journal of chemical physics

Published: March 08, 2013

Showing 1-8 of 8

Last Updated: 09/26/2026